Oxygen sensing and signal transduction in hypoxic pulmonary vasoconstriction

European Respiratory Journal

Volumn 47, Issue 1, 2016, Pages 288-303

  Sommer, Natascha ^a   Strielkov, Ievgen ^a   Pak, Oleg ^a   Weissmann, Norbert ^a  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL L TYPE; MYOSIN LIGHT CHAIN; NITRIC OXIDE; PHOSPHOLIPASE; PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSIENT RECEPTOR POTENTIAL CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL; CALCIUM; OXYGEN; VANILLOID RECEPTOR;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; HUMAN; HYPOXIC LUNG VASOCONSTRICTION; LUNG VENTILATION PERFUSION RATIO; MITOCHONDRIAL DYNAMICS; MUSCLE CONTRACTION; NONHUMAN; OXIDATION REDUCTION STATE; OXYGEN SENSING; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; CYTOLOGY; HYPOXIA; LUNG; LUNG CIRCULATION; METABOLISM; MITOCHONDRION; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY ARTERY; PULMONARY HYPERTENSION; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; VASOCONSTRICTION;

CALCIUM; CALCIUM CHANNELS; CALCIUM CHANNELS, L-TYPE; HUMANS; HYPERTENSION, PULMONARY; HYPOXIA; LUNG; MITOCHONDRIA; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NADPH OXIDASE; NITRIC OXIDE; OXYGEN; POTASSIUM CHANNELS, VOLTAGE-GATED; PULMONARY ARTERY; PULMONARY CIRCULATION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRPV CATION CHANNELS; VASOCONSTRICTION; VENTILATION-PERFUSION RATIO;

EID: 84954271441     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00945-2015     Document Type: Article

References (180)

1. Weissmann N, Akkayagil E, Quanz K, et al. Basic features of hypoxic pulmonary vasoconstriction in mice. Respir Physiol Neurobiol 2004; 139: 191-202.
2. Weissmann N, Grimminger F, Walmrath D, et al. Hypoxic vasoconstriction in buffer-perfused rabbit lungs. Respir Physiol 1995; 100: 159-169.
3. Lindgren L, Marshall C, Marshall BE. Hypoxic pulmonary vasoconstriction in isolated rat lungs perfused with perfluorocarbon emulsion. Acta Physiol Scand 1985; 123: 335-338.
4. Peake MD, Harabin AL, Brennan NJ, et al. Steady-state vascular responses to graded hypoxia in isolated lungs of five species. J Appl Physiol Respir Environ Exerc Physiol 1981; 51: 1214-1219.
5. Faraci FM, Kilgore DL Jr, Fedde MR. Attenuated pulmonary pressor response to hypoxia in bar-headed geese. Am J Physiol 1984; 247: R402-R403.
6. Malvin GM, Walker BR. Sites and ionic mechanisms of hypoxic vasoconstriction in frog skin. Am J Physiol Regul Integr Comp Physiol 2001; 280: R1308-R1314.
7. Skovgaard N, Abe AS, Andrade DV, et al. Hypoxic pulmonary vasoconstriction in reptiles: A comparative study of four species with different lung structures and pulmonary blood pressures. Am J Physiol Regul Integr Comp Physiol 2005; 289: R1280-R1288.
8. Olson KR, Russell MJ, Forster ME. Hypoxic vasoconstriction of cyclostome systemic vessels: The antecedent of hypoxic pulmonary vasoconstriction Am J Physiol Regul Integr Comp Physiol 2001; 280: R198-R206.
9. Smith MP, Russell MJ, Wincko JT, et al. Effects of hypoxia on isolated vessels and perfused gills of rainbow trout. Comp Biochem Physiol A Mol Integr Physiol 2001; 130: 171-181.
10. Lumb AB, Slinger P. Hypoxic pulmonary vasoconstriction: Physiology and anesthetic implications. Anesthesiology 2015; 122: 932-946.
11. Marshall BE. Hypoxic pulmonary vasoconstriction. Acta Anaesthesiol Scand Suppl 1990; 94: 37-41.
12. Naeije R, Brimioulle S. Physiology in medicine: Importance of hypoxic pulmonary vasoconstriction in maintaining arterial oxygenation during acute respiratory failure. Crit Care 2001; 5: 67-71.
13. Carter EP, Hartsfield CL, Miyazono M, et al. Regulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome. Am J Physiol Lung Cell Mol Physiol 2002; 283: L346-L353.
14. Sylvester JT, Shimoda LA, Aaronson PI, et al. Hypoxic pulmonary vasoconstriction. Physiol Rev 2012; 92: 367-520.
15. Weir EK. Does normoxic pulmonary vasodilatation rather than hypoxic vasoconstriction account for the pulmonary pressor response to hypoxia Lancet 1978; 1: 476-477.
16. Bradford JR, Dean HP. The pulmonary circulation. J Physiol 1894; 16: 34-158.
17. Plumier L. La circulation pulmonaire chez le chien [Pulmonary circulation in the dog]. Arch Intern Physiol 1904; 1: 176-213.
18. Von Euler US, Liljestrand G. Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol Scand 1946; 12: 301-320.
19. Motley HL, Cournand A, Werko L, et al. The influence of short periods of induced acute anoxia upon pulmonary artery pressures in man. Am J Physiol 1947; 150: 315-320.
20. Ariyaratnam P, Loubani M, Morice AH. Hypoxic pulmonary vasoconstriction in humans. Biomed Res Int 2013; 2013: 623684.
21. Hillier SC, Graham JA, Hanger CC, et al. Hypoxic vasoconstriction in pulmonary arterioles and venules. J Appl Physiol 1997; 82: 1084-1090.
22. Staub NC. Site of hypoxic pulmonary vasoconstriction. Chest 1985; 88: Suppl. 4, 240S-245S.
23. Kato M, Staub NC. Response of small pulmonary arteries to unilobar hypoxia and hypercapnia. Circ Res 1966; 19: 426-440.
24. Dawson CA, Grimm DJ, Linehan JH. Influence of hypoxia on the longitudinal distribution of pulmonary vascular resistance. J Appl Physiol Respir Environ Exerc Physiol 1978; 44: 493-498.
25. Marshall BE, Marshall C, Benumof J, et al. Hypoxic pulmonary vasoconstriction in dogs: Effects of lung segment size and oxygen tension. J Appl Physiol Respir Environ Exerc Physiol 1981; 51: 1543-1551.
26. Marshall C, Marshall BE. Influence of perfusate PO2 on hypoxic pulmonary vasoconstriction in rats. Circ Res 1983; 52: 691-696.
27. Leach RM, Robertson TP, Twort CH, et al. Hypoxic vasoconstriction in rat pulmonary and mesenteric arteries. Am J Physiol 1994; 266: L223-L231.
28. Murray TR, Chen L, Marshall BE, et al. Hypoxic contraction of cultured pulmonary vascular smooth muscle cells. Am J Respir Cell Mol Biol 1990; 3: 457-465.
29. Madden JA, Vadula MS, Kurup VP. Effects of hypoxia and other vasoactive agents on pulmonary and cerebral artery smooth muscle cells. Am J Physiol 1992; 263: L384-L393.
30. Vadula MS, Kleinman JG, Madden JA. Effect of hypoxia and norepinephrine on cytoplasmic free Ca2+ in pulmonary and cerebral arterial myocytes. Am J Physiol 1993; 265: L591-L597.
31. Salvaterra CG, Goldman WF. Acute hypoxia increases cytosolic calcium in cultured pulmonary arterial myocytes. Am J Physiol 1993; 264: L323-L328.
32. Fishman AP. Hypoxia on the pulmonary circulation. How and where it acts. Circ Res 1976; 38: 221-231.
33. Cutaia M, Rounds S. Hypoxic pulmonary vasoconstriction. Physiologic significance, mechanism, and clinical relevance. Chest 1990; 97: 706-718.
34. Davis MJ, Joyner WL, Gilmore JP. Microvascular pressure distribution and responses of pulmonary allografts and cheek pouch arterioles in the hamster to oxygen. Circ Res 1981; 49: 125-132.
35. van Heerden PV, Cameron PD, Karanovic A, et al. Orthodeoxia-an uncommon presentation following bilateral thoracic sympathectomy. Anaesth Intensive Care 2003; 31: 581-583.
36. Brimioulle S, Vachiry JL, Brichant JF, et al. Sympathetic modulation of hypoxic pulmonary vasoconstriction in intact dogs. Cardiovasc Res 1997; 34: 384-392.
37. Frostell C, Fratacci MD, Wain JC, et al. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83: 2038-2047.
38. Weissmann N, Winterhalder S, Nollen M, et al. NO and reactive oxygen species are involved in biphasic hypoxic vasoconstriction of isolated rabbit lungs. Am J Physiol Lung Cell Mol Physiol 2001; 280: L638-L645.
39. Bernal PJ, Leelavanichkul K, Bauer E, et al. Nitric-oxide-mediated zinc release contributes to hypoxic regulation of pulmonary vascular tone. Circ Res 2008; 102: 1575-1583.
40. Lahm T, Crisostomo PR, Markel TA, et al. Exogenous estrogen rapidly attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction. Shock 2008; 30: 660-667.
41. Farrukh IS, Peng W, Orlinska U, et al. Effect of dehydroepiandrosterone on hypoxic pulmonary vasoconstriction: A Ca2+-activated K+-channel opener. Am J Physiol 1998; 274: L186-L195.
42. Abid S, Houssaöni A, Mouraret N, et al. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension. Arterioscler Thromb Vasc Biol 2014; 34: 304-312.
43. Ketabchi F, Egemnazarov B, Schermuly RT, et al. Effects of hypercapnia with and without acidosis on hypoxic pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol 2009; 297: L977-L983.
44. Deem S, Berg JT, Kerr ME, et al. Effects of the RBC membrane and increased perfusate viscosity on hypoxic pulmonary vasoconstriction. J Appl Physiol 2000; 88: 1520-1528.
45. Shimoda LA, Laurie SS. HIF and pulmonary vascular responses to hypoxia. J Appl Physiol 2014; 116: 867-874.
46. Wenzel D, Matthey M, Bindila L, et al. Endocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction. Proc Natl Acad Sci USA 2013; 110: 18710-18715.
47. Yan G, Wang Q, Shi H, et al. Regulation of rat intrapulmonary arterial tone by arachidonic acid and prostaglandin E2 during hypoxia. PLoS One 2013; 8: E73839.
48. Strielkov IV, Kizub IV, Khromov AS, et al. Evidence for the role of phosphatidylcholine-specific phospholipase C in sustained hypoxic pulmonary vasoconstriction. Vascul Pharmacol 2013; 58: 292-298.
49. Weissmann N, Dietrich A, Fuchs B, et al. Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange. Proc Natl Acad Sci USA 2006; 103: 19093-19098.
50. Leach RM, Hill HM, Snetkov VA, et al. Divergent roles of glycolysis and the mitochondrial electron transport chain in hypoxic pulmonary vasoconstriction of the rat: Identity of the hypoxic sensor. J Physiol 2001; 536: 211-224.
51. Demiryurek AT, Wadsworth RM, Kane KA, et al. The role of endothelium in hypoxic constriction of human pulmonary artery rings. Am Rev Respir Dis 1993; 147: 283-290.
52. Demiryurek AT, Wadsworth RM, Kane KA. Effects of hypoxia on isolated intrapulmonary arteries from the sheep. Pulm Pharmacol 1991; 4: 158-164.
53. Liu Q, Sham JS, Shimoda LA, et al. Hypoxic constriction of porcine distal pulmonary arteries: Endothelium and endothelin dependence. Am J Physiol Lung Cell Mol Physiol 2001; 280: L856-L865.
54. Aaronson PI, Robertson TP, Ward JP. Endothelium-derived mediators and hypoxic pulmonary vasoconstriction. Respir Physiol Neurobiol 2002; 132: 107-120.
55. Robertson TP, Hague D, Aaronson PI, et al. Voltage-independent calcium entry in hypoxic pulmonary vasoconstriction of intrapulmonary arteries of the rat. J Physiol 2000; 525: 669-680.
56. Connolly MJ, Prieto-Lloret J, Becker S, et al. Hypoxic pulmonary vasoconstriction in the absence of pretone: Essential role for intracellular Ca2+ release. J Physiol 2013; 591: 4473-4498.
57. Wang L, Yin J, Nickles HT, et al. Hypoxic pulmonary vasoconstriction requires connexin 40-mediated endothelial signal conduction. J Clin Invest 2012; 122: 4218-4230.
58. Weir EK, Olschewski A. Role of ion channels in acute and chronic responses of the pulmonary vasculature to hypoxia. Cardiovasc Res 2006; 71: 630-641.
59. Robertson TP. Point: Release of an endothelium-derived vasoconstrictor and RhoA/Rho kinase-mediated calcium sensitization of smooth muscle cell contraction are/are not the main effectors for full and sustained hypoxic pulmonary vasoconstriction. J Appl Physiol 2007; 102: 2071-2072.
60. Waypa GB, Chandel NS, Schumacker PT. Model for hypoxic pulmonary vasoconstriction involving mitochondrial oxygen sensing. Circ Res 2001; 88: 1259-1266.
61. Rounds S, McMurtry IF. Inhibitors of oxidative ATP production cause transient vasoconstriction and block subsequent pressor responses in rat lungs. Circ Res 1981; 48: 393-400.
62. Weissmann N, Ebert N, Ahrens M, et al. Effects of mitochondrial inhibitors and uncouplers on hypoxic vasoconstriction in rabbit lungs. Am J Respir Cell Mol Biol 2003; 29: 721-732.
63. Michelakis ED, Thbaud B, Weir EK, et al. Hypoxic pulmonary vasoconstriction: Redox regulation of O2-sensitive K+ channels by a mitochondrial O2-sensor in resistance artery smooth muscle cells. J Mol Cell Cardiol 2004; 37: 1119-1136.
64. Sommer N, Pak O, Schrner S, et al. Mitochondrial cytochrome redox states and respiration in acute pulmonary oxygen sensing. Eur Respir J 2010; 36: 1056-1066.
65. Buescher PC, Pearse DB, Pillai RP, et al. Energy state and vasomotor tone in hypoxic pig lungs. J Appl Physiol 1991; 70: 1874-1881.
66. Fisher AB, Dodia C. Lung as a model for evaluation of critical intracellular PO2 and PCO. Am J Physiol 1981; 241: E47-E50.
67. Leach RM, Hill HS, Snetkov VA, et al. Hypoxia, energy state and pulmonary vasomotor tone. Respir Physiol Neurobiol 2002; 132: 55-67.
68. Sylvester JT. Hypoxic pulmonary vasoconstriction: A radical view. Circ Res 2001; 88: 1228-1230.
69. Sham JS. Hypoxic pulmonary vasoconstriction: Ups and downs of reactive oxygen species. Circ Res 2002; 91: 649-651.
70. Waypa GB, Schumacker PT. Hypoxic pulmonary vasoconstriction: Redox events in oxygen sensing. J Appl Physiol 2005; 98: 404-414.
71. Moudgil R, Michelakis ED, Archer SL. Hypoxic pulmonary vasoconstriction. J Appl Physiol 2005; 98: 390-403.
72. Ward JP. Point: Hypoxic pulmonary vasoconstriction is mediated by increased production of reactive oxygen species. J Appl Physiol 2006; 101: 993-995.
73. Archer SL, Huang J, Henry T, et al. A redox-based O2 sensor in rat pulmonary vasculature. Circ Res 1993; 73: 1100-1112.
74. Michelakis ED, Hampl V, Nsair A, et al. Diversity in mitochondrial function explains differences in vascular oxygen sensing. Circ Res 2002; 90: 1307-1315.
75. Michelakis ED, Archer SL, Weir EK. Acute hypoxic pulmonary vasoconstriction: A model of oxygen sensing. Physiol Res 1995; 44: 361-367.
76. Weir EK, Archer SL. The mechanism of acute hypoxic pulmonary vasoconstriction: The tale of two channels. FASEB J 1995; 9: 183-189.
77. Yuan XJ, Goldman WF, Tod ML, et al. Hypoxia reduces potassium currents in cultured rat pulmonary but not mesenteric arterial myocytes. Am J Physiol 1993; 264: L116-L123.
78. Post JM, Hume JR, Archer SL, et al. Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction. Am J Physiol 1992; 262: C882-C890.
79. Hasunuma K, Rodman DM, McMurtry IF. Effects of K+ channel blockers on vascular tone in the perfused rat lung. Am Rev Respir Dis 1991; 144: 884-887.
80. Patel AJ, Lazdunski M, Honor E. Kv2.1/Kv9.3, a novel ATP-dependent delayed-rectifier K+ channel in oxygen-sensitive pulmonary artery myocytes. EMBO J 1997; 16: 6615-6625.
81. Hulme JT, Coppock EA, Felipe A, et al. Oxygen sensitivity of cloned voltage-gated K+ channels expressed in the pulmonary vasculature. Circ Res 1999; 85: 489-497.
82. Archer SL, Souil E, Dinh-Xuan AT, et al. Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J Clin Invest 1998; 101: 2319-2330.
83. Reeve HL, Weir EK, Nelson DP, et al. Opposing effects of oxidants and antioxidants on K+ channel activity and tone in rat vascular tissue. Exp Physiol 1995; 80: 825-834.
84. Park MK, Bae YM, Lee SH, et al. Modulation of voltage-dependent K+ channel by redox potential in pulmonary and ear arterial smooth muscle cells of the rabbit. Pflugers Arch 1997; 434: 764-771.
85. Firth AL, Gordienko DV, Yuill KH, et al. Cellular localization of mitochondria contributes to Kv channel-mediated regulation of cellular excitability in pulmonary but not mesenteric circulation. Am J Physiol Lung Cell Mol Physiol 2009; 296: L347-L360.
86. Archer SL, London B, Hampl V, et al. Impairment of hypoxic pulmonary vasoconstriction in mice lacking the voltage-gated potassium channel Kv1.5. FASEB J 2001; 15: 1801-1803.
87. Sommer N, Dietrich A, Schermuly RT, et al. Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms. Eur Respir J 2008; 32: 1639-1651.
88. Archer S, Michelakis E. The mechanism(s) of hypoxic pulmonary vasoconstriction: Potassium channels, redox O2 sensors, and controversies. News Physiol Sci 2002; 17: 131-137.
89. Dikalov S, Griendling KK, Harrison DG. Measurement of reactive oxygen species in cardiovascular studies. Hypertension 2007; 49: 717-727.
90. Waypa GB, Marks JD, Guzy R, et al. Hypoxia triggers subcellular compartmental redox signaling in vascular smooth muscle cells. Circ Res 2010; 106: 526-535.
91. Weissmann N, Zeller S, Schfer RU, et al. Impact of mitochondria and NADPH oxidases on acute and sustained hypoxic pulmonary vasoconstriction. Am J Respir Cell Mol Biol 2006; 34: 505-513.
92. Desireddi JR, Farrow KN, Marks JD, et al. Hypoxia increases ROS signaling and cytosolic Ca2+ in pulmonary artery smooth muscle cells of mouse lungs slices. Antioxid Redox Signal 2010; 12: 595-602.
93. Sheehan DW, Giese EC, Gugino SF, et al. Characterization and mechanisms of H2O2-induced contractions of pulmonary arteries. Am J Physiol 1993; 264: H1542-H1547.
94. Jones RD, Thompson JS, Morice AH. The effect of hydrogen peroxide on hypoxia, prostaglandin F2 alpha and potassium chloride induced contractions in isolated rat pulmonary arteries. Pulm Pharmacol Ther 1997; 10: 37-42.
95. Olschewski A, Hong Z, Peterson DA, et al. Opposite effects of redox status on membrane potential, cytosolic calcium, and tone in pulmonary arteries and ductus arteriosus. Am J Physiol Lung Cell Mol Physiol 2004; 286: L15-L22.
96. Pourmahram GE, Snetkov VA, Shaifta Y, et al. Constriction of pulmonary artery by peroxide: Role of Ca2+ release and PKC. Free Radic Biol Med 2008; 45: 1468-1476.
97. Weir EK, Eaton JW, Chesler E. Redox status and pulmonary vascular reactivity. Chest 1985; 88: Suppl. 4, 249S-252S.
98. Hodyc D, Snorek M, Brtnicky T, et al. Superoxide dismutase mimetic tempol inhibits hypoxic pulmonary vasoconstriction in rats independently of nitric oxide production. Exp Physiol 2007; 92: 945-951.
99. Veit F, Pak O, Brandes RP, et al. Hypoxia-dependent reactive oxygen species signaling in the pulmonary circulation: focus on ion channels. Antioxid Redox Signal 2015; 22: 537-552.
100. Weissmann N, Grimminger F, Voswinckel R, et al. Nitro blue tetrazolium inhibits but does not mimic hypoxic vasoconstriction in isolated rabbit lungs. Am J Physiol 1998; 274: L721-L727.
101. Paky A, Michael JR, Burke-Wolin TM, et al. Endogenous production of superoxide by rabbit lungs: Effects of hypoxia or metabolic inhibitors. J Appl Physiol 1993; 74: 2868-2874.
102. Waypa GB, Guzy R, Mungai PT, et al. Increases in mitochondrial reactive oxygen species trigger hypoxia-induced calcium responses in pulmonary artery smooth muscle cells. Circ Res 2006; 99: 970-978.
103. Wang QS, Zheng YM, Dong L, et al. Role of mitochondrial reactive oxygen species in hypoxia-dependent increase in intracellular calcium in pulmonary artery myocytes. Free Radic Biol Med 2007; 42: 642-653.
104. Zaloudikova M, Herget J, Vizek M. The contractile response of isolated small pulmonary arteries induced by activated macrophages. Physiol Res 2014; 63: 267-270.
105. Turrens JF, Alexandre A, Lehninger AL. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophys 1985; 237: 408-414.
106. Paddenberg R, Ishaq B, Goldenberg A, et al. Essential role of complex II of the respiratory chain in hypoxia-induced ROS generation in the pulmonary vasculature. Am J Physiol Lung Cell Mol Physiol 2003; 284: L710-L719.
107. Brookes PS, Yoon Y, Robotham JL, et al. Calcium, ATP, and ROS: A mitochondrial love-hate triangle. Am J Physiol Cell Physiol 2004; 287: C817-C833.
108. Andrukhiv A, Costa AD, West IC, et al. Opening mitoKATP increases superoxide generation from complex I of the electron transport chain. Am J Physiol Heart Circ Physiol 2006; 291: H2067-H2074.
109. Bleier L, Drse S. Superoxide generation by complex III: from mechanistic rationales to functional consequences. Biochim Biophys Acta 2013; 1827: 1320-1331.
110. Korde AS, Yadav VR, Zheng YM, et al. Primary role of mitochondrial Rieske iron-sulfur protein in hypoxic ROS production in pulmonary artery myocytes. Free Radic Biol Med 2011; 50: 945-952.
111. Waypa GB, Marks JD, Guzy RD, et al. Superoxide generated at mitochondrial complex III triggers acute responses to hypoxia in the pulmonary circulation. Am J Respir Crit Care Med 2013; 187: 424-432.
112. Schumacker PT. Lung cell hypoxia: Role of mitochondrial reactive oxygen species signaling in triggering responses. Proc Am Thorac Soc 2011; 8: 477-484.
113. Chen Q, Vazquez EJ, Moghaddas S, et al. Production of reactive oxygen species by mitochondria: Central role of complex III. J Biol Chem 2003; 278: 36027-36031.
114. Paddenberg R, Tiefenbach M, Faulhammer P, et al. Mitochondrial complex II is essential for hypoxia-induced pulmonary vasoconstriction of intra-but not of pre-acinar arteries. Cardiovasc Res 2012; 93: 702-710.
115. Marshall C, Mamary AJ, Verhoeven AJ, et al. Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction. Am J Respir Cell Mol Biol 1996; 15: 633-644.
116. Mittal M, Gu XQ, Pak O, et al. Hypoxia induces Kv channel current inhibition by increased NADPH oxidase-derived reactive oxygen species. Free Radic Biol Med 2012; 52: 1033-1042.
117. Gabig TG, Bearman SI, Babior BM. Effects of oxygen tension and pH on the respiratory burst of human neutrophils. Blood 1979; 53: 1133-1139.
118. Weissmann N, Kuzkaya N, Fuchs B, et al. Detection of reactive oxygen species in isolated, perfused lungs by electron spin resonance spectroscopy. Respir Res 2005; 6: 86.
119. Weissmann N, Voswinckel R, Hardebusch T, et al. Evidence for a role of protein kinase C in hypoxic pulmonary vasoconstriction. Am J Physiol 1999; 276: L90-L95.
120. Ward JP, Knock GA, Snetkov VA, et al. Protein kinases in vascular smooth muscle tone-role in the pulmonary vasculature and hypoxic pulmonary vasoconstriction. Pharmacol Ther 2004; 104: 207-231.
121. Rathore R, Zheng YM, Niu CF, et al. Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through mitochondrial ROS-PKC signaling axis in pulmonary artery smooth muscle cells. Free Radic Biol Med 2008; 45: 1223-1231.
122. Moral-Sanz J, Gonzalez T, Menendez C, et al. Ceramide inhibits KV currents and contributes to TP-receptor-induced vasoconstriction in rat and human pulmonary arteries. Am J Physiol Cell Physiol 2011; 301: C186-C194.
123. Cogolludo A, Moreno L, Frazziano G, et al. Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction. Cardiovasc Res 2009; 82: 296-302.
124. Moreno L, Moral-Sanz J, Morales-Cano D, et al. Ceramide mediates acute oxygen sensing in vascular tissues. Antioxid Redox Signal 2014; 20: 1-14.
125. Frazziano G, Moreno L, Moral-Sanz J, et al. Neutral sphingomyelinase, NADPH oxidase and reactive oxygen species. Role in acute hypoxic pulmonary vasoconstriction. J Cell Physiol 2011; 226: 2633-2640.
126. Archer SL, Reeve HL, Michelakis E, et al. O2 sensing is preserved in mice lacking the gp91 phox subunit of NADPH oxidase. Proc Natl Acad Sci USA 1999; 96: 7944-7949.
127. Sumimoto H, Miyano K, Takeya R. Molecular composition and regulation of the Nox family NAD(P)H oxidases. Biochem Biophys Res Commun 2005; 338: 677-686.
128. Mittal M, Roth M, König P, et al. Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ Res 2007; 101: 258-267.
129. Wedgwood S, Lakshminrusimha S, Czech L, et al. Increased p22phox/Nox4 expression is involved in remodeling through hydrogen peroxide signaling in experimental persistent pulmonary hypertension of the newborn. Antioxid Redox Signal 2013; 18: 1765-1776.
130. Pendyala S, Moitra J, Kalari S, et al. Nrf2 regulates hyperoxia-induced Nox4 expression in human lung endothelium: Identification of functional antioxidant response elements on the Nox4 promoter. Free Radic Biol Med 2011; 50: 1749-1759.
131. Ahmad M, Kelly MR, Zhao X, et al. Roles for Nox4 in the contractile response of bovine pulmonary arteries to hypoxia. Am J Physiol Heart Circ Physiol 2010; 298: H1879-H1888.
132. Lee YM, Kim BJ, Chun YS, et al. Nox4 as an oxygen sensor to regulate TASK-1 activity. Cell Signal 2006; 18: 499-507.
133. Olschewski A, Li Y, Tang B, et al. Impact of TASK-1 in human pulmonary artery smooth muscle cells. Circ Res 2006; 98: 1072-1080.
134. Nagaraj C, Tang B, Balint Z, et al. Src tyrosine kinase is crucial for potassium channel function in human pulmonary arteries. Eur Respir J 2013; 41: 85-95.
135. Thomas HM 3rd, Carson RC, Fried ED, et al. Inhibition of hypoxic pulmonary vasoconstriction by diphenyleneiodonium. Biochem Pharmacol 1991; 42: R9-R12.
136. Grimminger F, Weissmann N, Spriestersbach R, et al. Effects of NADPH oxidase inhibitors on hypoxic vasoconstriction in buffer-perfused rabbit lungs. Am J Physiol 1995; 268: L747-L752.
137. Jones RD, Thompson JS, Morice AH. The NADPH oxidase inhibitors iodonium diphenyl and cadmium sulphate inhibit hypoxic pulmonary vasoconstriction in isolated rat pulmonary arteries. Physiol Res 2000; 49: 587-596.
138. Weissmann N, Tadic A, Hönze J, et al. Hypoxic vasoconstriction in intact lungs: A role for NADPH oxidase-derived H2O2 Am J Physiol Lung Cell Mol Physiol 2000; 279: L683-L690.
139. Mingone CJ, Gupte SA, Iesaki T, et al. Hypoxia enhances a cGMP-independent nitric oxide relaxing mechanism in pulmonary arteries. Am J Physiol Lung Cell Mol Physiol 2003; 285: L296-L304.
140. Wolin MS, Ahmad M, Gupte SA. Oxidant and redox signaling in vascular oxygen sensing mechanisms: basic concepts, current controversies, and potential importance of cytosolic NADPH. Am J Physiol Lung Cell Mol Physiol 2005; 289: L159-L173.
141. Gupte RS, Rawat DK, Chettimada S, et al. Activation of glucose-6-phosphate dehydrogenase promotes acute hypoxic pulmonary artery contraction. J Biol Chem 2010; 285: 19561-19571.
142. Olschewski A, Weir EK. Redox regulation of ion channels in the pulmonary circulation. Antioxid Redox Signal 2015; 22: 465-485.
143. Ohe M, Ogata M, Shirato K, et al. Effects of verapamil and BAY K 8644 on the hypoxic contraction of the isolated human pulmonary artery. Tohoku J Exp Med 1989; 157: 81-82.
144. Tucker A, McMurtry IF, Grover RF, et al. Attenuation of hypoxic pulmonary vasoconstriction by verapamil in intact dogs. Proc Soc Exp Biol Med 1976; 151: 611-614.
145. Tang C, To WK, Meng F, et al. A role for receptor-operated Ca2+ entry in human pulmonary artery smooth muscle cells in response to hypoxia. Physiol Res 2010; 59: 909-918.
146. Lin MJ, Yang XR, Cao YN, et al. Hydrogen peroxide-induced Ca2+ mobilization in pulmonary arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1598-L1608.
147. Liao B, Zheng YM, Yadav VR, et al. Hypoxia induces intracellular Ca2+ release by causing reactive oxygen species-mediated dissociation of FK506-binding protein 12.6 from ryanodine receptor 2 in pulmonary artery myocytes. Antioxid Redox Signal 2011; 14: 37-47.
148. Weigand L, Foxson J, Wang J, et al. Inhibition of hypoxic pulmonary vasoconstriction by antagonists of store-operated Ca2+ and nonselective cation channels. Am J Physiol Lung Cell Mol Physiol 2005; 289: L5-L13.
149. Goldenberg NM, Wang L, Ranke H, et al. TRPV4 is required for hypoxic pulmonary vasoconstriction. Anesthesiology 2015; 122: 1338-1348.
150. French RJ, Wells JB. Sodium ions as blocking agents and charge carriers in the potassium channel of the squid giant axon. J Gen Physiol 1977; 70: 707-724.
151. Fuchs B, Rupp M, Ghofrani HA, et al. Diacylglycerol regulates acute hypoxic pulmonary vasoconstriction via TRPC6. Respir Res 2011; 12: 20.
152. Weissmann N, Sydykov A, Kalwa H, et al. Activation of TRPC6 channels is essential for lung ischaemia-reperfusion induced oedema in mice. Nat Commun 2012; 3: 649.
153. Liu H, Zhang H, Forman HJ. Silica induces macrophage cytokines through phosphatidylcholine-specific phospholipase C with hydrogen peroxide. Am J Respir Cell Mol Biol 2007; 36: 594-599.
154. Monick MM, Carter AB, Gudmundsson G, et al. A phosphatidylcholine-specific phospholipase C regulates activation of p42/44 mitogen-activated protein kinases in lipopolysaccharide-stimulated human alveolar macrophages. J Immunol 1999; 162: 3005-3012.
155. Tabeling C, Yu H, Wang L, et al. CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction. Proc Natl Acad Sci USA 2015; 112: E1614-E1623.
156. Rathore R, Zheng YM, Li XQ, et al. Mitochondrial ROS-PKC signaling axis is uniquely involved in hypoxic increase in [Ca2+]i in pulmonary artery smooth muscle cells. Biochem Biophys Res Commun 2006; 351: 784-790.
157. Littler CM, Morris KG Jr, Fagan KA, et al. Protein kinase C-null mice have decreased hypoxic pulmonary vasoconstriction. Am J Physiol Heart Circ Physiol 2003; 284: H1321-H1331.
158. Jin N, Packer CS, Rhoades RA. Pulmonary arterial hypoxic contraction: Signal transduction. Am J Physiol 1992; 263: L73-L78.
159. Tsai BM, Wang M, Pitcher JM, et al. Hypoxic pulmonary vasoconstriction and pulmonary artery tissue cytokine expression are mediated by protein kinase C. Am J Physiol Lung Cell Mol Physiol 2004; 287: L1215-L1219.
160. Snetkov VA, Aaronson PI, Ward JP, et al. Capacitative calcium entry as a pulmonary specific vasoconstrictor mechanism in small muscular arteries of the rat. Br J Pharmacol 2003; 140: 97-106.
161. Jernigan NL, Paffett ML, Walker BR, et al. ASIC1 contributes to pulmonary vascular smooth muscle store-operated Ca2+ entry. Am J Physiol Lung Cell Mol Physiol 2009; 297: L271-L285.
162. Nitta CH, Osmond DA, Herbert LM, et al. Role of ASIC1 in the development of chronic hypoxia-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 2014; 306: H41-H52.
163. Gelband CH, Gelband H. Ca2+ release from intracellular stores is an initial step in hypoxic pulmonary vasoconstriction of rat pulmonary artery resistance vessels. Circulation 1997; 96: 3647-3654.
164. Morio Y, McMurtry IF. Ca2+ release from ryanodine-sensitive store contributes to mechanism of hypoxic vasoconstriction in rat lungs. J Appl Physiol 2002; 92: 527-534.
165. Jabr RI, Toland H, Gelband CH, et al. Prominent role of intracellular Ca2+ release in hypoxic vasoconstriction of canine pulmonary artery. Br J Pharmacol 1997; 122: 21-30.
166. Kang TM, Park MK, Uhm DY. Characterization of hypoxia-induced [Ca2+]i rise in rabbit pulmonary arterial smooth muscle cells. Life Sci 2002; 70: 2321-2333.
167. Dipp M, Nye PC, Evans AM. Hypoxic release of calcium from the sarcoplasmic reticulum of pulmonary artery smooth muscle. Am J Physiol Lung Cell Mol Physiol 2001; 281: L318-L325.
168. Zhang J, Zhou J, Cai L, et al. Extracellular calcium-sensing receptor is critical in hypoxic pulmonary vasoconstriction. Antioxid Redox Signal 2012; 17: 471-484.
169. Aaronson PI. Hypoxic pulmonary vasoconstriction is/is not mediated by increased production of reactive oxygen species. J Appl Physiol 2006; 101: 1000.
170. Shigemori K, Ishizaki T, Matsukawa S, et al. Adenine nucleotides via activation of ATP-sensitive K+ channels modulate hypoxic response in rat pulmonary artery. Am J Physiol 1996; 270: L803-L809.
171. Leach RM, Sheehan DW, Chacko VP, et al. Energy state, pH, and vasomotor tone during hypoxia in precontracted pulmonary and femoral arteries. Am J Physiol Lung Cell Mol Physiol 2000; 278: L294-L304.
172. Evans AM, Mustard KJ, Wyatt CN, et al. Does AMP-activated protein kinase couple inhibition of mitochondrial oxidative phosphorylation by hypoxia to calcium signaling in O2-sensing cells J Biol Chem 2005; 280: 41504-41511.
173. Robertson TP, Mustard KJ, Lewis TH, et al. AMP-activated protein kinase and hypoxic pulmonary vasoconstriction. Eur J Pharmacol 2008; 595: 39-43.
174. Sarre A, Lange N, Kucera P, et al. MitoKATP channel activation in the postanoxic developing heart protects E-C coupling via NO-, ROS-, and PKC-dependent pathways. Am J Physiol Heart Circ Physiol 2005; 288: H1611-H1619.
175. Paddenberg R, Faulhammer P, Goldenberg A, et al. Impact of modulators of mitochondrial ATP-sensitive potassium channel (mitoKATP) on hypoxic pulmonary vasoconstriction. Adv Exp Med Biol 2009; 648: 361-368.
176. Li X, Rapedius M, Baukrowitz T, et al. 5-Hydroxydecanoate and coenzyme A are inhibitors of native sarcolemmal KATP channels in inside-out patches. Biochim Biophys Acta 2010; 1800: 385-391.
177. Olson KR, Deleon ER, Gao Y, et al. Thiosulfate: A readily accessible source of hydrogen sulfide in oxygen sensing. Am J Physiol Regul Integr Comp Physiol 2013; 305: R592-R603.
178. Olson KR, Whitfield NL, Bearden SE, et al. Hypoxic pulmonary vasodilation: A paradigm shift with a hydrogen sulfide mechanism. Am J Physiol Regul Integr Comp Physiol 2010; 298: R51-R60.
179. Skovgaard N, Olson KR. Hydrogen sulfide mediates hypoxic vasoconstriction through a production of mitochondrial ROS in trout gills. Am J Physiol Regul Integr Comp Physiol 2012; 303: R487-R494.
180. Prieto-Lloret J, Shaifta Y, Ward JP, et al. Hypoxic pulmonary vasoconstriction in isolated rat pulmonary arteries is not inhibited by antagonists of H2S-synthesizing pathways. J Physiol 2015; 593: 385-401.